Table. 2.

Table. 2.

Intraoperative and postoperative course

Variable All patients (n = 303) IOC (n = 215, 71.0%) No-IOC (n = 88, 29.0%) p-value
Trained surgeon 213 (70.3) 160 (74.4) 53 (60.2) 0.01*
Operative time 60 (35–210) 70 (45–210) 55 (35–130) 0.01*
Drainage 44 (14.5) 31 (14.4) 13 (14.8) > 0.99
Intraoperative complications 5 (1.7) 4 (1.9) 1 (1.1) > 0.99
Bleeding 4 (1.3) 3 (1.4) 1 (1.1)
Biliary injury 1 (0.3) 1 (0.5) 0 (0.0)
Conversion 3 (1.0) 2 (0.9) 1 (1.1) > 0.99
Bleeding 1 (0.3) 0 (0.0) 1 (1.1)
Biliary injury 1 (0.3) 1 (0.5) 0 (0.0)
Adhesions 1 (0.3) 1 (0.5) 0 (0.0)
Ambulatory surgery 203 (67.0) 147 (68.4) 56 (63.6) 0.40
Hospital stay (day) 0.64 ± 1.74 0.75 ± 1.90 0.64 ± 1.17 0.20
30-Day postoperative complications 11 (3.6) 11 (5.1) 0 (0.0) 0.03*
Bleeding 3 (1.0) 3 (1.4) 0 (0.0)
Surgical site infections 2 (0.7) 2 (0.9) 0 (0.0)
Biliary injury 3 (1.0) 3 (1.4) 0 (0.0)
Collection 1 (0.3) 1 (0.5) 0 (0.0)
Gallstones biliary disorder 2 (0.7) 2 (0.9) 0 (0.0)
Re-operation 5 (1.7) 5 (2.3) 0 (0.0) 0.30
Bleeding 3 (1.0) 3 (1.4) 0 (0.0)
Biliary injury 1 (0.3) 1 (0.5) 0 (0.0)
Surgical site infections 1 (0.3) 1 (0.5) 0 (0.0)
Postoperative ERCP 9 (3.0) 9 (4.2) 0 (0.0) 0.06
Programmed 7 (2.3) 7 (3.3) 0 (0.0)
Non-programmed 2 (0.7) 2 (0.9) 0 (0.0)
90-Day biliary injury 3 (1.0) 3 (1.4) 0 (0.0) 0.50

Values are presented as number (%), mean (range), or mean ± standard deviation.

IOC, intraoperative cholangiography; ERCP, endoscopic retrograde cholangiopancreatography.

*Statistically significant p < 0.05.

Ann Hepatobiliary Pancreat Surg 2023;27:166-71 https://doi.org/10.14701/ahbps.22-099
© 2023 Ann Hepatobiliary Pancreat Surg